TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35276716

Group type: EXPERIMENTAL
Intervention: Lurasidone 40-80 mg/d
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Lurasidone 120-160 mg/d
Number of subjects: 328

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Lurasidone 40-160 mg/d
Number of subjects: 328
Study: 35961517

Group type: EXPERIMENTAL
Intervention: High dose of autologous skeletal muscle–derived cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low dose of autologous skeletal muscle–derived cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cell-free medium (Control)
Number of subjects: 0
Study: 33949726

Group type: EXPERIMENTAL
Intervention: AVATAR therapy
Number of subjects: 25
Study: 32447858

Group type: EXPERIMENTAL
Intervention: Nerve trunk stimulation therapy (Chize, Neiguan, Xiaohai)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (acupuncture intervention)
Number of subjects: 42
Study: 34407031

Group type: EXPERIMENTAL
Intervention: Active drug
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 32440111

Group type: EXPERIMENTAL
Intervention: Nebulized glycopyrrolate (GLY) 25 µg twice daily (BID)
Number of subjects: 861

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 861
Study: 35952325

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 90
Study: 33521131

Group type: EXPERIMENTAL
Intervention: Deep cervical flexor (DCF) muscle training using pressure biofeedback in addition to conventional exercises for neck pain.
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional exercises only (Control group).
Number of subjects: 65
Study: 32483072

Group type: EXPERIMENTAL
Intervention: Femtosecond laser‐assisted cataract surgery (FLACS)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional phacoemulsification cataract surgery (CPS)
Number of subjects: 96
Study: 35357281

Group type: EXPERIMENTAL
Intervention: Behaviour change interventions at Healthy Life Centres (HLCs)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Short, additional healthy eating education programme
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 118
Study: 33721102

Group type: EXPERIMENTAL
Intervention: Severe vitamin D deficiency
Number of subjects: 10
Study: 32661292

Group type: EXPERIMENTAL
Intervention: Sedentary Time (ST)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 232
Study: 34173900

Group type: EXPERIMENTAL
Intervention: Sibling opportunity to say goodbye
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Presence at the death
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Wishing they had done something differently
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Mother reports of sibling internalizing symptoms
Number of subjects: 88
Study: 34528132

Group type: EXPERIMENTAL
Intervention: 75 mL water (HYP)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Volume of water equal to 90% of sweat losses (EU)
Number of subjects: 14
Study: 33185325

Group type: EXPERIMENTAL
Intervention: PEG-IFNα/TDF
Number of subjects: 120

Group type: COMPARATOR
Intervention: PEG-IFNα/PBO
Number of subjects: 120
Study: 36107497

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT)
Number of subjects: 30
Study: 33892653

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.1 mg/kg intravenous bolus 10 hours before surgery)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 116
Study: 32233940

Group type: EXPERIMENTAL
Intervention: guselkumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 0
Study: 34939580

Group type: EXPERIMENTAL
Intervention: Pentavac vaccine
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Shan 5 vaccine
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Pentabio vaccine
Number of subjects: 900

Group type: COMPARATOR
Intervention: Local adverse events
Number of subjects: 900

Group type: COMPARATOR
Intervention: Systemic adverse events
Number of subjects: 900
Study: 32285233

Group type: EXPERIMENTAL
Intervention: Understanding Our Peers with Pablo programme
Number of subjects: 222

Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 222
Study: 35323106

Group type: EXPERIMENTAL
Intervention: Plyometric Training (PT)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Isometric Strength Training (IST)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Overall (PT and IST)
Number of subjects: 26
Study: 33626198

Group type: EXPERIMENTAL
Intervention: Manual Therapy & Exercises Group (MTEG)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Home Exercises Group (HEG)
Number of subjects: 17
Study: 32492206

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 strain from Bangladesh
Number of subjects: 0
Study: 35416908

Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 171
Study: 34563973

Group type: EXPERIMENTAL
Intervention: Oral Ketamine
Number of subjects: 30
Study: 36004709

Group type: EXPERIMENTAL
Intervention: HD + P. ostreatus (1 kg of P. ostreatus per week, four portions of 250 g)
Number of subjects: 30

Group type: COMPARATOR
Intervention: HD (healthy diet without edible mushrooms)
Number of subjects: 30
Study: 32068241

Group type: EXPERIMENTAL
Intervention: Lacosamide
Number of subjects: 61

Group type: COMPARATOR
Intervention: Carbamazepine-CR
Number of subjects: 61
Study: 34774485

Group type: EXPERIMENTAL
Intervention: Friedewald-calculated LDL-C
Number of subjects: 6122

Group type: EXPERIMENTAL
Intervention: Martin-Hopkins-calculated LDL-C
Number of subjects: 6122

Group type: EXPERIMENTAL
Intervention: NIH equation 2-calculated LDL-C
Number of subjects: 6122

Group type: EXPERIMENTAL
Intervention: NIH equation 2
Number of subjects: 6122

Group type: EXPERIMENTAL
Intervention: All three methods (Friedewald, Martin-Hopkins, NIH equation 2)
Number of subjects: 6122
Study: 32781440

Group type: EXPERIMENTAL
Intervention: Combined sleep hygiene recommendations and mindfulness intervention
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (unassisted sleep during a tournament week)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Baseline (unassisted, habitual sleep during a regular training week)
Number of subjects: 17
Study: 33945982

Group type: EXPERIMENTAL
Intervention: Thiamine 200 mg IV three times daily for 7 days
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 32103358

Group type: EXPERIMENTAL
Intervention: BLESS program (12-week social capital-based exercise adherence program)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (written information on exercise)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups (BLESS program and control)
Number of subjects: 48
Study: 35593783

Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erenumab (both doses)
Number of subjects: 0
Study: 32963063

Group type: EXPERIMENTAL
Intervention: Educational intervention targeting general practitioners (GPs) with a rapid referral service for quick insertion
Number of subjects: 0
Study: 35016629

Group type: EXPERIMENTAL
Intervention: Virtual Reality-based Motor Control Training (VRT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional Occupational Therapy (COT)
Number of subjects: 30
Study: 32290266

Group type: EXPERIMENTAL
Intervention: SettleIN programme
Number of subjects: 19

Group type: COMPARATOR
Intervention: Residential care as usual
Number of subjects: 19
Study: 36371623

Group type: EXPERIMENTAL
Intervention: Technology-based Comprehensive Cardiac Rehabilitation Therapy (TaCT) electronic cardiac rehabilitation (eCR) intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 33757774

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both arms (Fractional CO2 laser and Sham)
Number of subjects: 30
Study: 35567653

Group type: EXPERIMENTAL
Intervention: Pacritinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 33132345

Group type: EXPERIMENTAL
Intervention: Grape Seed Extract (GSE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 20
Study: 36324127

Group type: EXPERIMENTAL
Intervention: Twice-daily test mouth rinse containing Cetylpyridinium chloride (CPC) and essential oils for 12 weeks
Number of subjects: 118

Group type: COMPARATOR
Intervention: Carrier rinse control for 12 weeks
Number of subjects: 118
Study: 34889785

Group type: EXPERIMENTAL
Intervention: Flap fixation method
Number of subjects: 105
Study: 35482016

Group type: EXPERIMENTAL
Intervention: Imaging (ultrasound followed by CT if necessary)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Observation (reassessed after 6-8 hours with repeated scoring)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Imaging
Number of subjects: 181

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 181
Study: 32699282

Group type: EXPERIMENTAL
Intervention: Burst-tree decomposition method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kernel-based model for generating event sequences
Number of subjects: 0
Study: 36435542

Group type: EXPERIMENTAL
Intervention: Cognitive restructuring plus imagery rescripting (CR + ImRs)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Therapist attention placebo plus imagery rescripting (PLA + ImRs)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Double therapist attention placebo (PLA + PLA)
Number of subjects: 53
Study: 36123102

Group type: EXPERIMENTAL
Intervention: Highly absorbable oral curcumin (brand name: curcuRouge)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33105889

Group type: EXPERIMENTAL
Intervention: CATCH‐IT (Competent Adulthood Transition with Cognitive‐behavioral, Humanistic, and Interpersonal Training)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Online health education (HE)
Number of subjects: 0
Study: 35943804

Group type: EXPERIMENTAL
Intervention: Sham-controlled surgical intervention
Number of subjects: 1

Group type: COMPARATOR
Intervention: Sham surgery
Number of subjects: 1
Study: 34391532

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.2 mg
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.1 mg
Number of subjects: 180

Group type: COMPARATOR
Intervention: Laser therapy
Number of subjects: 180
Study: 33176727

Group type: EXPERIMENTAL
Intervention: Female treatment and concurrent male partner treatment (7 days of combined antibiotics - oral metronidazole 400 mg BID and 2% clindamycin cream applied topically to the glans penis and upper shaft BID)
Number of subjects: 342

Group type: COMPARATOR
Intervention: Current standard of care (female treatment only)
Number of subjects: 342
Study: 34036237

Group type: EXPERIMENTAL
Intervention: Reduced intensity conditioning (RIC)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Myeloablative conditioning (MAC)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Testing positive for mutations
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Testing additional genes
Number of subjects: 48
Study: 33593139

Group type: EXPERIMENTAL
Intervention: Fortified feed with 1% olive leaves extract
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Fortified feed with 1.5% olive leaves extract
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Fortified feed with 2% olive leaves extract
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group diet without olive leaves extract
Number of subjects: 400
Study: 34006237

Group type: EXPERIMENTAL
Intervention: Yam Daabo interventions (refresher training for providers, counseling tool, supportive supervision, availability of contraceptive services 7 days a week, client appointment cards, invitation letters for partners)
Number of subjects: 555

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 555
Study: 32209963

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Group D)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (Group C)
Number of subjects: 30
Study: 35660501

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (24‐h fast, 3 non‐consecutive days per week) in mice
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (24‐h fast, 3 non‐consecutive days per week) in humans (IF70)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (ad libitum feeding) in mice
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (IF100) in humans
Number of subjects: 58
Study: 34154319

Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam (C/T)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Aminoglycosides/colistin/combination
Number of subjects: 405
Study: 32087836

Group type: EXPERIMENTAL
Intervention: MI-based treatment engagement intervention (TE)
Number of subjects: 86

Group type: COMPARATOR
Intervention: non-MI assessment and information control (CON)
Number of subjects: 86
Study: 33196574

Group type: EXPERIMENTAL
Intervention: Music intervention before and during surgery
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 165
Study: 32147362

Group type: EXPERIMENTAL
Intervention: Selonsertib 18 mg
Number of subjects: 1594

Group type: EXPERIMENTAL
Intervention: Selonsertib 6 mg
Number of subjects: 1594

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1594
Study: 36246987

Group type: EXPERIMENTAL
Intervention: Continuous nursing based on mobile platform
Number of subjects: 104

Group type: COMPARATOR
Intervention: Routine follow-up nursing
Number of subjects: 104
Study: 34959801

Group type: EXPERIMENTAL
Intervention: 1000 mg/day DHA
Number of subjects: 0

Group type: COMPARATOR
Intervention: 200 mg/day DHA
Number of subjects: 0
Study: 34128219

Group type: EXPERIMENTAL
Intervention: CBT-3M (cognitive-focused intervention)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 37
Study: 33275134

Group type: EXPERIMENTAL
Intervention: High-dose trivalent influenza vaccine
Number of subjects: 5260

Group type: COMPARATOR
Intervention: Standard-dose quadrivalent influenza vaccine
Number of subjects: 5260
Study: 34371978

Group type: EXPERIMENTAL
Intervention: Isocarbohydrate (IC) preload with apple (A + 35R)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypercarbohydrate (HC) preload with apple (A + 50R)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All preload treatments (IC and HC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference (W + 50R)
Number of subjects: 0
Study: 32333168

Group type: EXPERIMENTAL
Intervention: Bright white light therapy (BWLT) - 10,000 lx, active arm, twice-daily 1-hour sessions for 4 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Dim red light therapy (DRLT) - < 300 lx, control arm, twice-daily 1-hour sessions for 4 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Comparison between BWLT and DRLT
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Quality of life metrics
Number of subjects: 35
Study: 32574773

Group type: EXPERIMENTAL
Intervention: AKB-9778 treatment
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Baseline metrics (FAZ area, presence of IRMA, peripapillary VD)
Number of subjects: 73
Study: 37061370

Group type: EXPERIMENTAL
Intervention: Low dose (0.5 mL) HPV vaccine
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: High dose (1.0 mL) HPV vaccine
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo (aluminum adjuvant)
Number of subjects: 160
Study: 33388129

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33297622

Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 19546

Group type: EXPERIMENTAL
Intervention: Fecal Immunochemical Test (FIT)
Number of subjects: 19546

Group type: EXPERIMENTAL
Intervention: Novel risk-adapted screening approach
Number of subjects: 19546

Group type: EXPERIMENTAL
Intervention: Novel risk-adapted screening approach (high-risk participants)
Number of subjects: 19546

Group type: EXPERIMENTAL
Intervention: Novel risk-adapted screening approach (low-risk participants)
Number of subjects: 19546
Study: 35290446

Group type: EXPERIMENTAL
Intervention: Dynamic daylight (DDL) condition
Number of subjects: 17

Group type: COMPARATOR
Intervention: Habitual light (HL) condition
Number of subjects: 17
Study: 33435904

Group type: EXPERIMENTAL
Intervention: Rifampicin (300 mg bd)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ursodeoxycholic acid (up to 2000 mg daily)
Number of subjects: 0
Study: 36334013

Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 400

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 400
Study: 34086541

Group type: EXPERIMENTAL
Intervention: Risk factors including depressed mood, availability of illegal drugs, sensation-seeking behavior, social learning, peer's drug use
Number of subjects: 8079

Group type: EXPERIMENTAL
Intervention: Protective factor: positive outlook of the future
Number of subjects: 8079
Study: 34916649

Group type: EXPERIMENTAL
Intervention: RCT with guided tissue regeneration (GTR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: RCT without guided tissue regeneration (GTR)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: RCT with mineral trioxide aggregate (MTA) obturation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: RCT with gutta percha (GP) obturation
Number of subjects: 120
Study: 35068204

Group type: EXPERIMENTAL
Intervention: Standardized patient actor training
Number of subjects: 0
Study: 33316199

Group type: EXPERIMENTAL
Intervention: Attitudes Toward LGBT People Scale
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: Religiosity
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: Cisgender female students
Number of subjects: 1007
Study: 35313763

Group type: EXPERIMENTAL
Intervention: HPV self-sampling
Number of subjects: 12572

Group type: COMPARATOR
Intervention: Reminder for Pap test
Number of subjects: 12572
Study: 33183504

Group type: EXPERIMENTAL
Intervention: Transcatheter bariatric embolotherapy (TBE) targeting the left gastric artery using an occlusion balloon microcatheter to administer 300- to 500-μm embolic beads; patients also entered a lifestyle counseling program.
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham procedure; patients also entered a lifestyle counseling program.
Number of subjects: 44
Study: 34756492

Group type: EXPERIMENTAL
Intervention: Potential-CT-benefit-ANN model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Eighth AJCC staging system
Number of subjects: 0
Study: 36414931

Group type: EXPERIMENTAL
Intervention: WebQuit
Number of subjects: 316

Group type: COMPARATOR
Intervention: Smokefree
Number of subjects: 316
Study: 34364011

Group type: EXPERIMENTAL
Intervention: Home-based high-intensity respiratory muscle training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 0
Study: 32530368

Group type: EXPERIMENTAL
Intervention: Stressor condition
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 130
Study: 35417762

Group type: EXPERIMENTAL
Intervention: Conventional Plus Fluciclovine (18F) PET (arm 2)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Conventional only (arm 1)
Number of subjects: 165
Study: 33764818

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Everolimus
Number of subjects: 0
Study: 32302205

Group type: EXPERIMENTAL
Intervention: PLLA-HA screw
Number of subjects: 40

Group type: COMPARATOR
Intervention: Titanium screw
Number of subjects: 40
Study: 35918788

Group type: EXPERIMENTAL
Intervention: 10 ml levobupivacaine 0.25%
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 20 ml levobupivacaine 0.25%
Number of subjects: 48
Study: 34369699

Group type: EXPERIMENTAL
Intervention: Moxibustion combined with pelvic floor muscle function training
Number of subjects: 150

Group type: COMPARATOR
Intervention: Pelvic floor muscle function training
Number of subjects: 150
Study: 36792254

Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 1858

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1858

Group type: EXPERIMENTAL
Intervention: MAE (both PCI and CABG)
Number of subjects: 1858

Group type: EXPERIMENTAL
Intervention: Major or minor bleeding with blood transfusion ≥2 U (both PCI and CABG)
Number of subjects: 1858

Group type: EXPERIMENTAL
Intervention: Stroke, unplanned revascularization for ischemia, renal failure (CABG only)
Number of subjects: 1858
Study: 33235284

Group type: EXPERIMENTAL
Intervention: Behavioral pharmacology (alcohol administration)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Medications that reduced stimulation, sedation, and craving during alcohol administration
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Leave-one-out Monte Carlo analysis
Number of subjects: 118
Study: 32997422

Group type: COMPARATOR
Intervention: Nontreatment seekers
Number of subjects: 240
Study: 35832097

Group type: EXPERIMENTAL
Intervention: Occupational Performance Coaching (OPC) and Four-Quadrant Model of Facilitated Learning (4QM) interventions
Number of subjects: 6
Study: 33032975

Group type: EXPERIMENTAL
Intervention: Age quartile groups (0-3.3 years median interval between CCTA)
Number of subjects: 1153

Group type: COMPARATOR
Intervention: Lowest age quartile group
Number of subjects: 1153
Study: 35191412

Group type: EXPERIMENTAL
Intervention: HIIT-short
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: HIIT-long
Number of subjects: 20

Group type: COMPARATOR
Intervention: MICT
Number of subjects: 20
Study: 33770195

Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise training for 12 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 35
Study: 32437690

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (atDCS) at 2 mA for 20 minutes, 3 times per week for 4 weeks (12 sessions)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo stimulation (control group)
Number of subjects: 45
Study: 36100520

Group type: EXPERIMENTAL
Intervention: Intralesional injection of platelet-rich plasma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0